Mitochondria as Targets for Phytochemicals in Cancer Prevention and Therapy

Transcription

1 Mitochondria as Targets for Phytochemicals in Cancer Prevention and Therapy

2 Dhyan Chandra Editor Mitochondria as Targets for Phytochemicals in Cancer Prevention and Therapy 1 3

3 Editor Dhyan Chandra, Associate Professor Pharmacology and Therapeutics Center for Genetics and Pharmacology Roswell Park Cancer Institute Buffalo New York USA ISBN ISBN (ebook) DOI / Springer New York Heidelberg Dordrecht London Library of Congress Control Number: Springer Science+Business Media New York 2013 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. Exempted from this legal reservation are brief excerpts in connection with reviews or scholarly analysis or material supplied specifically for the purpose of being entered and executed on a computer system, for exclusive use by the purchaser of the work. Duplication of this publication or parts thereof is permitted only under the provisions of the Copyright Law of the Publisher s location, in its current version, and permission for use must always be obtained from Springer. Permissions for use may be obtained through RightsLink at the Copyright Clearance Center. Violations are liable to prosecution under the respective Copyright Law. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. While the advice and information in this book are believed to be true and accurate at the date of publication, neither the authors nor the editors nor the publisher can accept any legal responsibility for any errors or omissions that may be made. The publisher makes no warranty, express or implied, with respect to the material contained herein. Printed on acid-free paper Springer is part of Springer Science+Business Media (

4 Preface The mitochondrion, an organelle within cells, has long been considered to be the powerhouse of the cell because of its central role in energy production. However, in the last two decades it has become clear that mitochondria also play a key role in cell survival and cell death. More recent findings further implicate a broader perspective on the role of mitochondria in multiple cellular signaling. Defects in mitochondria are associated with the genesis of multiple diseases, including cancer. One of the key functions of mitochondria is to induce cell death in multiple types of cells under physiological or environmental stresses. However, their cell-death inducing function may be defective in cancer, causing survival and proliferation of cancer cells. Although one of the drawbacks of current cancer therapy is resistance to cell death as a result of defective mitochondrial pathways, these defects provide an opportunity to target tumor mitochondria selectively to induce cancer cell death. Selectively targeting tumor mitochondrial pathways may also decrease toxicity to normal tissues possessing normal functional mitochondria, and thus further enhance therapeutic efficacy. During the last decade there has been significant emphasis on preventing or curing cancer with natural remedies involving the use of naturally derived phytochemicals, which possess anticancer properties with minimal toxicity. Although further studies are warranted, significant progress has been made investigating the role of mitochondria in controlling cancer cell death and proliferation in response to phytochemicals. This book describes the current status of the impact of phytochemicals on cancer cell death and survival. The key role of mitochondria in cancer prevention and therapy is also illustrated. The book contains contributions from multiple researchers working in the areas of cancer, phytochemistry, and mitochondria. This comprehensive collection of information will be useful to a broadbased audience with a focus on cancer research, prevention, and treatment. I highly acknowledge the unwavering support and enthusiasm of all the authors and am grateful for their contributions of the chapters in the area of their expertise. I also owe a debt of gratitude to numerous researchers who reviewed the chapters and provided constructive criticism. Buffalo, New York, USA Dhyan Chandra, Associate Professor v

5 Contents 1 OxPhos Defects and Their Role in Cancer Initiation and Progression... 1 Nagendra Yadava, Ahmed Khalil and Sallie S. Schneider 2 Estrogen Receptor Tumor Suppressor Protein p53 Signaling Crosstalk as Potential Targets of Xenoestrogens Gokul M. Das 3 Mitochondrial Regulation of Cell-Death Richard Jäger and Howard O. Fearnhead 4 Cell-Death Inducing Mechanisms of Cancer Chemopreventive Agents Vijay Mohan, Dhanya Nambiar, Raosaheb K. Kale and Rana P. Singh 5 Dietary Phytochemicals Target Cancer Stem Cells for Cancer Chemoprevention Dunne Fong and Marion M. Chan 6 Basic and Translational Research on Dietary Phytochemicals and Cancer Prevention Ashraful Hoque and Xiao-Chun Xu 7 Mitochondrial Reactive Oxygen Species in Proapoptotic Effect of Promising Cancer Chemopreventive Phytochemicals Anuradha Sehrawat and Shivendra V. Singh 8 Therapeutic Action of Phytochemicals on Cancer Stem Cells O. Leis, J. Gumuzio and Angel G. Martin vii

6 viii Contents 9 Phytochemicals, micrornas, and Cancer: Implications for Cancer Prevention and Therapy Sanjeev K. Srivastava, Sumit Arora, Seema Singh and Ajay P. Singh 10 Optical Imaging of Mitochondria for Canc er Therapy Jonathan F. Lovell 11 Targeting Cellular Signaling for Cancer Prevention and Therapy by Phytochemicals Fang Hao, Neelu Yadav and Dhyan Chandra Index

7 Contributors Sumit Arora Mitchell Cancer Institute, University of South Alabama, Mobile, AL, USA Marion M. Chan Department of Microbiology and Immunology, Temple University School of Medicine, Philadelphia, PA, USA Dhyan Chandra Department of Pharmacology and Therapeutics, Center for Genetics and Pharmacology Roswell Park Cancer Institute, Buffalo, New York, USA Gokul M. Das Department of Pharmacology and Therapeutics, Center for Genetics and Pharmacology, Roswell Park Cancer Institute, Buffalo, NY, USA Howard O. Fearnhead Pharmacology and Therapeutics, NUI Galway, Galway, Ireland Dunne Fong Department of Cell Biology and Neuroscience, Rutgers, The State University of New Jersey, Piscataway, NJ, USA J. Gumuzio Regulation of Cell Growth Laboratory, Fundacion Inbiomed, San Sebastian, Spain Fang Hao Department of Pharmacology and Therapeutics, Center for Genetics and Pharmacology Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, New York, USA Ashraful Hoque Department of Clinical Cancer Prevention, Unit 1360, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Richard Jäger University of Applied Sciences Bonn-Rhein-Sieg, Rheinbach, Germany Raosaheb K. Kale School of Life Sciences, Central University of Gujarat, Gandhinagar, Gujarat, India Cancer Biology Laboratory, School of Life Sciences, Jawaharlal Nehru University, New Delhi, India ix

8 x Contributors Ahmed Khalil Pioneer Valley Life Sciences Institute, Springfield, MA, USA Department of Biology, University of Massachusetts, Amherst, MA, USA O. Leis Regulation of Cell Growth Laboratory, Fundacion Inbiomed, San Sebastian, Spain Jonathan F. Lovell Department of Chemical and Biological Engineering, University at Buffalo, Buffalo, USA Department of Biomedical Engineering, University at Buffalo, Buffalo, USA Angel G. Martin Fundación Inbiomed, San Sebastian, Gipuzkoa, Spain Vijay Mohan School of Life Sciences, Central University of Gujarat, Gandhinagar, Gujarat, India Dhanya Nambiar Cancer Biology Laboratory, School of Life Sciences, Jawaharlal Nehru University, New Delhi, India School of Environmental Sciences, Jawaharlal Nehru University, New Delhi, India Anuradha Sehrawat Department of Pharmacology & Chemical Biology, University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA Seema Singh Mitchell Cancer Institute, University of South Alabama, Mobile, AL, USA Ajay P. Singh Mitchell Cancer Institute, University of South Alabama, Mobile, AL, USA Department of Biochemistry and Molecular Biology, University of South Alabama, Mobile, AL, USA Rana P. Singh School of Life Sciences, Central University of Gujarat, Gandhinagar, Gujarat, India School of Life Sciences, Jawaharlal Nehru University, New Delhi, India Cancer Biology Laboratory, School of Life Sciences, Jawaharlal Nehru University, New Delhi, India Shivendra V. Singh Department of Pharmacology & Chemical Biology, University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA Sallie S. Schneider Pioneer Valley Life Sciences Institute, Springfield, MA, USA Department of Veterinary and Animal Sciences, University of Massachusetts, Amherst, MA, USA Sanjeev K. Srivastava Mitchell Cancer Institute, University of South Alabama, Mobile, AL, USA Neelu Yadav Department of Pharmacology and Therapeutics, Center for Genetics and Pharmacology Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, New York, USA

9 Contributors xi Nagendra Yadava Pioneer Valley Life Sciences Institute, Springfield, MA, USA Division of Endocrinology, Diabetes and Metabolism, Baystate Medical Center of Tufts University School of Medicine, Springfield, MA, USA Department of Biology, University of Massachusetts, Amherst, MA, USA Xiao-Chun Xu Department of Clinical Cancer Prevention, Unit 1360, The University of Texas MD Anderson Cancer Center, Houston, TX, USA